These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12163255)

  • 1. Medication errors reported to the vaccine adverse event reporting system (VAERS).
    Varricchio F
    Vaccine; 2002 Aug; 20(25-26):3049-51. PubMed ID: 12163255
    [No Abstract]   [Full Text] [Related]  

  • 2. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013.
    Hibbs BF; Moro PL; Lewis P; Miller ER; Shimabukuro TT
    Vaccine; 2015 Jun; 33(28):3171-8. PubMed ID: 25980429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety.
    Haber P; Iskander J; Walton K; Campbell SR; Kohl KS
    Pediatrics; 2011 May; 127 Suppl 1():S39-44. PubMed ID: 21502243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS).
    Braun MM; Mootrey GT; Salive ME; Chen RT; Ellenberg SS
    Pediatrics; 2000 Oct; 106(4):E51. PubMed ID: 11015546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing data mining methods on the VAERS database.
    Banks D; Woo EJ; Burwen DR; Perucci P; Braun MM; Ball R
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):601-9. PubMed ID: 15954077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventable mix-ups of tuberculin and vaccines: reports to the US Vaccine and Drug Safety Reporting Systems.
    Chang S; Pool V; O'Connell K; Polder JA; Iskander J; Sweeney C; Ball R; Braun MM
    Drug Saf; 2008; 31(11):1027-33. PubMed ID: 18840022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the Vaccine Adverse Event Reporting System database.
    Geier DA; Geier MR
    Expert Opin Pharmacother; 2004 Mar; 5(3):691-8. PubMed ID: 15013937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who is unlikely to report adverse events after vaccinations to the Vaccine Adverse Event Reporting System (VAERS)?
    McNeil MM; Li R; Pickering S; Real TM; Smith PJ; Pemberton MR
    Vaccine; 2013 May; 31(24):2673-9. PubMed ID: 23597717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Announcement: Implementation of the Vaccine Adverse Event Reporting System 2.0 Reporting Form.
    MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(27):738. PubMed ID: 28704349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013.
    Haber P; Moro PL; McNeil MM; Lewis P; Woo EJ; Hughes H; Shimabukuro TT
    Vaccine; 2014 Nov; 32(48):6499-504. PubMed ID: 25258101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental regression and autism reported to the Vaccine Adverse Event Reporting System.
    Woo EJ; Ball R; Landa R; Zimmerman AW; Braun MM;
    Autism; 2007 Jul; 11(4):301-10. PubMed ID: 17656395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of stratification on data mining in the US Vaccine Adverse Event Reporting System (VAERS).
    Woo EJ; Ball R; Burwen DR; Braun MM
    Drug Saf; 2008; 31(8):667-74. PubMed ID: 18636785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
    Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M
    Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major Birth Defects after Vaccination Reported to the Vaccine Adverse Event Reporting System (VAERS), 1990 to 2014.
    Moro PL; Cragan J; Lewis P; Sukumaran L
    Birth Defects Res; 2017 Jul; 109(13):1057-1062. PubMed ID: 28762675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group.
    Singleton JA; Lloyd JC; Mootrey GT; Salive ME; Chen RT
    Vaccine; 1999 Jul; 17(22):2908-17. PubMed ID: 10438063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
    Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
    Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases.
    Felicetti P; Trotta F; Bonetto C; Santuccio C; Brauchli Pernus Y; Burgner D; Chandler R; Girolomoni G; Hadden RD; Kochhar S; Kucuku M; Monaco G; Ozen S; Pahud B; Phuong L; Bachtiar NS; Teeba A; Top K; Varricchio F; Wise RP; Zanoni G; Živkovic S; Bonhoeffer J;
    Vaccine; 2016 Dec; 34(51):6634-6640. PubMed ID: 26392009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.
    Geier D; Geier MR
    Int J Toxicol; 2004; 23(6):369-76. PubMed ID: 15764492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.